The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BSH 2019 | Communication between CLL patients and doctors
Ben Kennedy, MB ChB, FRCP(UK), FRCPath, University Hospitals of Leicester NHS Trust, Leicester, speaks from the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK. He discusses the importance of open and upfront communications between doctors and patients, and gives his perspective on watch-and-wait, also called active observation, in chronic lymphocytic leukemia (CLL).
